Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis-Reference-Cited by-同舟云学术

Exacerbation of Ulcerative Colitis with Tocilizumab: A Report of Two Cases, One with Takayasu Arteritis and the Other with Relapsing Polychondritis

Published:2021-05-15 Issue:10 Volume:60 Page:1615-1620
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hanioka Yusuke¹,Shimizu Katsushu¹,Yamagami Keiko¹,Yao Shuhei¹,Nakamura Ryota¹,Nakamura Tomoyuki¹,Goto Hitoshi¹

Affiliation:

1. Department of Internal Medicine, Osaka City General Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/60/10/60_5215-20/_pdf

Reference28 articles.

1. 1. Nakaoka Y, Isobe M, Takei S, et al. Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomized, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study). Ann Rheum Dis 77: 348-354, 2018.

2. 2. Moulis G, Pugnet G, Costedoat-Chalumeau N, et al. Efficacy and safety of biologics in relapsing polychondritis: a French national multicentre study. Ann Rheum Dis 77: 1172-1178, 2018.

3. 3. Ungaro R, Colombel JF, Lissoos T, Peyrin-Biroulet L. A treatment-to-target update in ulcerative colitis: a systematic review. Am J Gastroenterol 114: 874-883, 2019.

4. 4. Terao C, Matsumura T, Yoshifuji H, et al. Takayasu arteritis and ulcerative colitis: high rate of co-occurrence and genetic overlap. Arthritis Rheumatol 67: 2226-2232, 2015.

5. 5. Cantarini L, Vitale A, Brizi MG, et al. Diagnosis and classification of relapsing polychondritis. J Autoimmun 48-49: 53-59, 2014.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tocilizumab unfolds colo-protective and immunomodulatory effect in experimentally induced ulcerative colitis via mitigating autophagy and ER stress signaling;Inflammopharmacology;2024-08-12

2. Successful Response to Golimumab in a Case of Relapsing Polychondritis Overlapping with Ulcerative Colitis;Biologics: Targets and Therapy;2024-01

3. Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease;Chinese Medical Journal;2023-07-07

4. Targeting IL-6 trans-signalling: past, present and future prospects;Nature Reviews Immunology;2023-04-17

5. Canthin-6-Ones: Potential Drugs for Chronic Inflammatory Diseases by Targeting Multiple Inflammatory Mediators;Molecules;2023-04-11